LivaNova PLC LIVN

Company Overview

LivaNova PLC is a global medical technology company focused on the development and commercialization of advanced therapies and medical devices. The company operates primarily within the medical devices and healthcare technology industries, with a focus on improving outcomes for patients with cardiovascular and neurological conditions. LivaNova’s core revenue is driven by implantable devices, capital equipment, and related disposables used in both acute hospital settings and long-term chronic disease management.

The company’s primary business lines are Cardiopulmonary and Neuromodulation, serving hospitals, clinicians, and patients across developed and select emerging markets. LivaNova is known for its strong clinical evidence base, long product lifecycles, and specialized expertise in high-acuity therapies. The company was formed in 2015 through the merger of Sorin S.p.A., an Italian cardiovascular device manufacturer, and Cyberonics, Inc., a U.S.-based neuromodulation company, creating a diversified medical technology platform with global reach.